Concerta ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
20322q11.2 deletion syndrome1

203. 22q11.2 deletion syndrome


Clinical trials : 5 Drugs : 7 - (DrugBank : 1) / Drug target genes : 14 - Drug target pathways : 23
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04647500
(ClinicalTrials.gov)
August 26, 20163/11/2020Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion SyndromeEffects of Modulation of the Dopaminergic System Using Methylphenidate on Memory and Executive Processes in Individuals With 22q11.2 Deletion Syndrome22q11.2 Deletion SyndromeDrug: ConcertaUniversity of Geneva, SwitzerlandNULLCompleted8 Years25 YearsAll45N/ASwitzerland